3HR1

Discovery of novel inhibitors of PDE10A

Summary for 3HR1

Entry DOI	10.2210/pdb3hr1/pdb
Related	3HQW 3HQY 3HQZ
Descriptor	cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A, SULFATE ION, 2-{[4-(1-methyl-4-pyridin-4-yl-1H-pyrazol-3-yl)phenoxy]methyl}quinoline, ... (6 entities in total)
Functional Keywords	phosphodiesterase 10a, pde 10a, pde10 inhibitors, allosteric enzyme, alternative splicing, camp, camp-binding, cgmp, cgmp-binding, cytoplasm, hydrolase, magnesium, metal-binding, nucleotide-binding, zinc, hydrolase-hydrolase inhibitor complex, hydrolase/hydrolase inhibitor
Biological source	Rattus norvegicus (rat)
Cellular location	Cytoplasm: Q9QYJ6
Total number of polymer chains	1
Total formula weight	44340.28
Authors	Pandit, J.,Marr, E.S. (deposition date: 2009-06-08, release date: 2009-08-04, Last modification date: 2023-09-06)
Primary citation	Verhoest, P.R.,Chapin, D.S.,Corman, M.,Fonseca, K.,Harms, J.F.,Hou, X.,Marr, E.S.,Menniti, F.S.,Nelson, F.,O'Connor, R.,Pandit, J.,Proulx-Lafrance, C.,Schmidt, A.W.,Schmidt, C.J.,Suiciak, J.A.,Liras, S. Discovery of a Novel Class of Phosphodiesterase 10A Inhibitors and Identification of Clinical Candidate 2-[4-(1-Methyl-4-pyridin-4-yl-1H-pyrazol-3-yl)-phenoxymethyl]-quinoline (PF-2545920) for the Treatment of Schizophrenia J.Med.Chem., 52:5188-5196, 2009 Cited by PubMed: 19630403 DOI: 10.1021/jm900521k PDB entries with the same primary citation
Experimental method	X-RAY DIFFRACTION (1.53 Å)

Structure validation